Frontage Clinical
Secaucus, New Jersey, 07094, United States
NCT Number: NCT07492355
This clinical trial will determine the bioavailability and effect of food on TP-3654 in healthy adult participants.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 1
Secaucus, New Jersey, 07094, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
capsule, oral administered
Time frame: 13 days
Analysis of the maximum concentration (Cmax) of the relative bioavailability of TP-3654 in two different capsule formulations utilizing the ratio of adjusted geometric means
Time frame: 13 days
Analysis of the maximum concentration (Cmax) of the relative bioavailability of the selected capsule formulation of TP-3654 from Part A when administered in fed versus fasting conditions utilizing the ratio of adjusted geometric means.
Time frame: 13 days
Analysis of the area under the concentration (AUC) time curve of the relative bioavailability of TP-3654 in two different capsule formulations utilizing the ratio of adjusted geometric means
Time frame: 13 days
Analysis of the area under the concentration (AUC) time curve of the relative bioavailability of the selected capsule formulation of TP-3654 from Part A when administered in fed versus fasting conditions utilizing the ratio of adjusted geometric means.
Time frame: 47 days
Sumitomo Pharma America, Inc.
Industry
A Phase 1 Randomized Study in Healthy Adult Participants to Assess the Relative Bioavailability of and Effect of Food on TP-3654 Capsule Formulations
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03326310
Bone Marrow Diseases, Chronic Disease
Chicago, Illinois, United States
View Trial DetailsNCT03480360
Acute Myeloid Leukemia, Anemia
Lebanon, New Hampshire, United States
View Trial DetailsNCT03427866
Bone Marrow Diseases, Hematologic Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT00081874
Bone Marrow Diseases, Chronic Disease
Houston, Texas, United States
View Trial Details